mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.01 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.01 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.01 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |